Correlation Between Aqueous Protein Level and Clinical Grading of Flare and Flaremetry.
NCT ID: NCT01905579
Last Updated: 2014-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2013-03-31
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Changes in OCT Biomarkers After the First Intravitreal Anti-VEGF Injection in Treatment-naïve DME
NCT06841250
Optical Coherence Tomography in the Diagnosis of Scleritis and Episcleritis
NCT01958567
Identification and Measurement of Antioxidants and Cytokines in the Anterior Chamber of Various Ocular Disorders
NCT04101591
Imaging of Retinochoroidal Vasculature in Patients Being Assessed for Cardiovascular Disease
NCT05082402
"Predicting Glaucoma Progression With Optical Coherence Tomography Structural and Angiographic Parameters".
NCT04646122
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with uveitis
Paracentesis of the anterior chamber in Paients with uveitis undergoing cataract surgery
Paracentesis of the anterior chamber
Aqueous humor parenthesis for quantitative protein analysis in patients with and without uveitis.
patients without uveitis
Paracentesis of the anterior chamber in patients without uveitis undergoing routine cataract surgery
Paracentesis of the anterior chamber
Aqueous humor parenthesis for quantitative protein analysis in patients with and without uveitis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Paracentesis of the anterior chamber
Aqueous humor parenthesis for quantitative protein analysis in patients with and without uveitis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 10 patients without uveitis with cataract
* Inactive inflammation for at least 3 months
Exclusion Criteria
* endophthalmitis
* cases with corneal scar
10 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Eye Center and The Eye Foundation for Research in Ophthalmology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samir S. Shoughy, MD, FRCS (Glasg.)
Ophthalmologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samir S Shoughy
Role: PRINCIPAL_INVESTIGATOR
THE EYE CENTER
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Eye Center
Riyadh, , Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Shoughy SS, Elkum N, Tabbara KF. Aqueous protein level and flare grading. Acta Ophthalmol. 2015 Mar;93(2):e173-4. doi: 10.1111/aos.12522. Epub 2014 Aug 31. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TEC 2012-003
Identifier Type: OTHER
Identifier Source: secondary_id
TEC 123
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.